The DOI matches its Crossref record.
Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty‐five patients
Abstract
Objective: Because the optimal cyclophosphamide (CY) treatment duration for severe polyarteritis nodosa (PAN) without virus infection and microscopic polyangiitis (MPA) has not been established, we conducted a trial to compare the effectiveness of 6 versus 12 CY pulses given in combination with corticosteroids (CS). Methods: Sixty‐five (18 PAN, 47 MPA) previously untreated patients were randomized to receive 12 (n = 34) or 6 (n = 31) CY pulses combined with CS. PAN and MPA were histologically proven or met ACR criteria. All patients presented ≥1 factor of severity according to the five factor score (FFS). CY pulses were administered every 2 weeks for 1 month, then every 4 weeks. The end point of the study was the number of events (relapses and/or deaths) occurring in each group, analyzed according to an intention‐to‐treat strategy. The outcome was evaluated by Cox proportional hazards analysis. Results: The baseline characteristics were similar for both groups. The mean (± SD) followup was 32 ± 21 months. Survival analysis showed a significantly lower relapse probability (P = 0.02; hazards ratio [HR] = 0.34) and higher event‐free survival (P = 0.02, HR = 0.44) for the 12 CY‐pulse group while the mortality rates were not significantly different (P = 0.47). Conclusion: These results suggest that 6 CY pulses are less effective than 12 CY pulses to treat severe PAN and MPA, particularly with respect to the risk of relapses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 21
- 10.1002/art.1780370206 · DOI · Paper page
- 10.1016/S0140-6736(97)80118-3 · DOI · Paper page
- 10.1002/art.1780330805 · DOI
- 10.1097/00005792-199601000-00003 · DOI · Paper page
- 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A · DOI · Paper page
- 10.7326/0003-4819-116-6-488 · DOI · Paper page
- Luqmani R, 1999, A multicenter randomised trial of cyclophosphamide versus azathioprine during remission in ANCA‐associated vasculitis (CYCAZAREM), Arthritis Rheum, 42, S225
- 10.1093/qjmed/90.6.401 · DOI · Paper page
- 10.1002/art.1780401213 · DOI · Paper page
- Guillevin L, 1992, Treatment of polyarteritis nodosa and Churg‐Strauss syndrome: a meta‐analysis of 3 prospective controlled trials including 182 patients over 12 years, Ann Méd Interne (Paris), 143, 405
- 10.1093/rheumatology/36.12.1290 · DOI · Paper page
- 10.1097/00005792-199509000-00002 · doi:10.1097/00005792-199509000-00002
- Luqmani RA, 1994, Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis, Q J Med, 87, 671
- 10.1046/j.1523-1755.1998.00807.x · DOI · Paper page
- 10.1080/01621459.1958.10501452 · DOI · Paper page
- Cox D, 1972, Regression models and life tables, J R Stat Soc, 34, 187
- 10.1002/art.1780381116 · DOI · Paper page
- 10.1002/1529-0131(200012)43:12<2853::AID-ANR30>3.0.CO;2-G · doi:10.1002/1529-0131(200012)43:12<2853::aid-anr30>3.0.co;2-g
- Bartolucci P, 2001, Pilot study on infliximab for 10 patients with systemic vasculitis not responding to steroids and immunosuppressants, Arthritis Rheum, 44, S56
- Lamprecht P, 2001, Successful treatment of refractory Wegener's granulomatosis with infliximab, Arthritis Rheum, 44, S56
- Bacon PA, 1998, Immune ablation with peripheral blood stem cell rescue in Wegener's systemic vasculitis, Clin Exp Immunol, 112, S57
Cited by
de Groot, K., Harper, L., Jayne, D. R. W., Flores Suarez, L. F., Gregorini, G., Gross, W. L., Luqmani, R., Pusey, C. D., Rasmussen, N., Sinico, R. A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-10-200905190-00004 · Cited by 957
Self-citationGuillevin, L., Pagnoux, C., Seror, R., Mahr, A., Mouthon, L., & Toumelin, P. L. (2011) · Medicine · doi:10.1097/md.0b013e318205a4c6 · Cited by 951
Self-citationHellmich, B., Flossmann, O., Gross, W. L., Bacon, P., Willem Cohen-Tervaert, J., Guillevin, L., Jayne, D., Mahr, A., Merkel, P. A., Raspe, H., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062711 · Cited by 633
Self-citationPagnoux, C., Seror, R., Henegar, C., Mahr, A., Cohen, P., Le Guern, V., Bienvenu, B., Mouthon, L., & Guillevin, L. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27240 · Cited by 571
Self-citationHogan, S. L., Falk, R. J., Chin, H., Cai, J., Jennette, C. E., Jennette, J. C., & Nachman, P. H. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-9-200511010-00005 · Cited by 479
Harper, L., Morgan, M. D., Walsh, M., Hoglund, P., Westman, K., Flossmann, O., Tesar, V., Vanhille, P., Groot, K. D., Luqmani, R., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200477 · Cited by 432
Self-citationMukhtyar, C., Flossmann, O., Hellmich, B., Bacon, P., Cid, M., Cohen-Tervaert, J. W., Gross, W. L., Guillevin, L., Jayne, D., Mahr, A., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071936 · Cited by 419
Self-citationJais, X., Launay, D., Yaici, A., Le Pavec, J., Tchérakian, C., Sitbon, O., Simonneau, G., & Humbert, M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23303 · Cited by 398
Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of action
Buttgereit, F., Straub, R. H., Wehling, M., & Burmester, G. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20583 · Cited by 367
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)
Mohammad, A. J., Hot, A., Arndt, F., Moosig, F., Guerry, M.-J., Amudala, N., Smith, R., Sivasothy, P., Guillevin, L., Merkel, P. A., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206095 · Cited by 268
Self-citationNociplastic pain: the prominent role of non-neuronal cells in central and peripheral sensitization
Lai, W., Tang, X., Chen, S., Zhou, Y., Qi, Z., Cao, M., Yuan, C., Yu, J., & Wen, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1677310 · Cited by 5
Metadata
- Authors
- Guillevin, L., Cohen, P., Mahr, A., Arène, J., Mouthon, L., Puéchal, X., Pertuiset, E., Gilson, B., Hamidou, M., Lanoux, P., Bruet, A., Ruivard, M., Vanhille, P., & Cordier, J.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2003-02-07
- Volume
- 49
- Issue
- 1
- Pages
- 93-100
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2022541722
- Cited by
- 251
- References
- 0
- FWCI
- 9.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Hospices Civils de Lyon
- Association pour la Recherche sur les Angéites Nécrosantes (ARAN)
- UPRES EA-3409 Recherche clinique et thérapeutique
- Université de Paris-Nord
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.